We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...
About Twist Bioscience Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the ...
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate ...
Discovering Twist Bioscience: A Closer Look Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology.
Hosted on MSN1mon
Twist Bioscience CEO Emily Leproust sells $256,630 in company stockTwist Bioscience, a company based in South San Francisco, California, operates in the biological products sector, focusing on DNA synthesis for various applications in health care, agriculture ...
the company has been attracting attention for its innovative approaches to DNA synthesis and storage. Twist Bioscience's financial performance has shown mixed results. InvestingPro analysis ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector ...
With a market capitalization of approximately $3.1 billion as of February 2025, the company has been attracting attention for its innovative approaches to DNA synthesis and storage. Twist Bioscience's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results